Again, we will be using this iCannabinoid platform to update everyone step by step with our progress.

It looks like we will need to activate the...Again, we will be using this iCannabinoid platform to update everyone step by step with our progress.

It looks like we will need to activate the iCannabinoid Ambassador Program faster than we wanted just to handle the demand for real, good, timely information on all our initiatives. Maybe next week we can start that process, if you have already signed up we will be contacting each and everyone, if you have not signed up yet please do so asap! It pretty much covers all industry sectors and services, it's a pretty robust initiative.
Thank you for your Support!

Yes. The news release states "all our shares will remain intact" (remain the same) as we transition into a private company. It does not matter what price the shares trade at right now or during the transition, perhaps a buying opportunity or perhaps not, you be the judge! Maybe someone wants to give them away for free (0). I will take them all. Sometimes we don't get all the inside information we want, that's usually because "when it's real" it has not happened yet, however all the signs are usually there. We just need to use our common sense and make a decision.

You are correct, there are many opportunities for us, IPO or even RTO scenarios and plenty of expanded operations CBIS-EDP opportunities that have been made available to us. We are looking at many through financings and public company licensing deals and partnerships. Some do work out and advance us forward and others do not. We will continue building operations and strength while we proceed with the IPO master plan at the same time.

"We are designing some sort of timeline tracking system that updates so the questions can be answered in one spot and everyone can have instant access to the real time information tracking our drug development progress and how to purchase new product releases, our CBIS-EDP operations, financings, acquisitions, partnerships and trading status. Will take a minute, but we get the job done."

Talk soon.

Thanks Raymond Show more

Nice questions, Really, it all depends on what "your" intentions are for the Company. You can clearly see the future growth and outstanding medical drug...Nice questions, Really, it all depends on what "your" intentions are for the Company. You can clearly see the future growth and outstanding medical drug development progress we have made. This is why we are here in the first place.

You can clearly see the CBIS-EDP opportunities we are making available to the general public based on the progress the Company has made over the last few years ending up straight into Harvard. You can clearly see the progress in our CBIS -EDP and how it is actually taking off Worldwide. The CBIS -EDP is covering so many different industries that the money making economic changing opportunities we all have in that program is massive.

We as stated in the news release are in the middle of a very painful growth transition. We are negotiating and structuring a few very large financings and a new stock market liquidity path, it's already underway and it's all based on the success and growth we are clearly in the middle of. We realize the choices to succeed in our operations was the right one.

Also as stated in the news release, we are now paying the price for the choices made to attain that growth and success. I think we will all do very well.

Again, it depends on what your intentions are. Are you here to help or hinder ?? Only you really know that. We know why we are here. Killing cancer and going after a number of other nasty ailment targets so aggressively while we are educating and trying to help create jobs worldwide through our CBIS - EDP.

That's why we are here, we are gaining momentum everyday. So no matter what happens, it is a profound thing we are a part of right now and making history in unchartered territory in so many areas, we are all a part of that.

We can all stand up tall and be Proud to say we helped move this ball and come down to Harvard or watch the Harvard GHC Summit videos for the last three years and see for yourself and actually take part. That's why we are here.

I'm quite positive that once we complete the operational expansions, and perhaps even before we start trading again with a new stock symbol there will be people who will have the proper paperwork that will probably want to buy all of your shares. I'm quite certain we will all do very well regardless.

Again, we will be updating everyone here step by step with our progress.
We designing some sort of timeline tracking system that updates so the questions can be answered in one spot and everyone can have instant access to the real time information tracking our drug development progress and how to purchase new product releases, our CBIS-EDP operations, financings, acquisitions, partnerships and trading status. Will take a minute, but we get the job done.

This chapter has just begun. However, as you can see our Journey is well underway the ups and the downs, the failures, and the successes. So yeah we think it's worth it.

Talk soon.

Thanks,
Raymond Show more

Hey Joel, you should read my posts. Thanks Raymond

It's Great to see that certain people want to push the envelope for inside information. Unfortunately, there is none when the actions have not taken...It's Great to see that certain people want to push the envelope for inside information. Unfortunately, there is none when the actions have not taken place yet.

Fortunately, I do not give any inside information unless you are an insider and then you would know the legal (Law) constraints.

We are not quite a private company yet.

Sorry if you didn't understand.
I will be clear, again:

Moving forward we will be posting step by step updates here on iCannabinoid.
Nothing else has been announced yet, as we are just getting started.

Thanks for your Support!

Raymond Show more

Hey Thomas,

Sorry if you didn't understand.
Please let me be clear:

Moving forward we will be posting step by step updates here on iCannabinoid.Hey Thomas,

Sorry if you didn't understand.
Please let me be clear:

Moving forward we will be posting step by step updates here on iCannabinoid.
Nothing else has been announced yet, as we are just getting started.

Thanks for your Support!

Raymond Show more

Thanks to everyone for your continued support and joining iCannabinoid for updates and current information!

I've been updating this info for now...Thanks to everyone for your continued support and joining iCannabinoid for updates and current information!

I've been updating this info for now until we launch our proper information flow.
I’m excited, this is going to get real good!

We haven't even released the full CBIS-EDP website yet!


The News Release simply states:

"All Cannabis Science shareholders and their shareholdings will remain intact under the same name and entity, Cannabis Science Inc., a Nevada Corporation.

All Cannabis Science shareholders of record as of the last day trading whether individuals or entities will be eligible for the first rights IPO offering and shareholder loyalty gifts; all other new shareholders will be officially closed-out once the transition to private company status has occurred."

*** This means all your shares will stay intact when we go “Private”, you will receive the loyalty shareholder gift, and when we do an IPO you will have the first rights to purchase more. I think we might have a different valuation by then.

Moving forward we will be posting step by step updates here on iCannabinoid.

Based on the success we have been building; I think we will all do very well!

Talk soon.

Thanks,
Raymond Show more

Thanks for updating the post Tony!

Just as the news simply states; all your shares will stay intact as private company shares while we go through...Thanks for updating the post Tony!

Just as the news simply states; all your shares will stay intact as private company shares while we go through the transition stage and coupled with the fact that you have first rights to more when we do the IPO if you still own them.

We will be posting step by step updates here on iCannabinoid for each step thereafter. There are many options for creating shareholder liquidity and value. I'm quite certain we will all be Happy !!!

Raymond Show more

Timothy, we will be posting step by step progress right here if you do not understand that part of the news release.

This is Only the Beginning!...Timothy, we will be posting step by step progress right here if you do not understand that part of the news release.

This is Only the Beginning! Thanks for your continued support! I think we all will be very Happy!

Cheers, Raymond Show more

Just Released !!! New Era !!! New Growth !!! New Beginnings !!!


Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes...Just Released !!! New Era !!! New Growth !!! New Beginnings !!!


Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth

Irvine, CA - (NewMediaWire) - October 21, 2019 - Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has agreed to go private under sanctions by the U.S. Securities and Exchange Commission (“SEC”). All Cannabis Science shareholders and their shareholdings will remain intact under the same name and entity, Cannabis Science Inc., a Nevada Corporation. Cannabis Science shares will no longer be quoted or traded on any stock market exchange.

Once the private corporation status takes effect the Company’s President will begin the steps to file a Dutch auction IPO targeting $25,000,000 USD or more with all current shareholders intact with completed financials, first rights IPO offerings for current shareholders, new shareholder IPO offerings, and a new company trading symbol. All Cannabis Science shareholders of record as of the last day trading whether individuals or entities will be eligible for the first rights IPO offering and shareholder loyalty gifts; all other new shareholders will be officially closed-out once the transition to private company status has occurred.

Cannabis Science Inc. President and CEO Raymond C. Dabney stated, “This is probably one of the most exciting times for Cannabis Science in terms of the rate of our growth and the number of international positive cash flow projects the company is entering into right now through its Economic Development Program (CBIS-EDP). We are certainly transitioning into a very large multi-national conglomerate real fast and we must guide this massive battleship home with ease and control. As we transition into ‘Step (2)’ of this growth, the associated growing pains we are experiencing right now have certainly shaken up and taken a toll on the company’s operations and our complete line of auditing and fully reporting capabilities. After extensive communications with the SEC regarding our business growth and how best to manage it with the SEC’s reporting requirements and information-flow constraints, I have come to realize that this is the best course of action right now so we can focus on growing our business and becoming cash-flow positive. With that in mind, I agree with the SEC on this one; it is time to make the required moves to protect our successful business growth and as a result protect our shareholders’ value.

“All shareholders will be able to register on www.iCannabinoid.com to get live access to current financial information, share trading status, new acquisitions, partnerships and opportunities, news releases, progress reports, presentations, new financings, first rights IPO opportunities and shareholder loyalty gifts. As well, inside of the iCannabinoid website we will be offering businesses, students, and entrepreneurs everywhere full access to our university economic development plan (CBIS-EDP) categorized by Countries, Regions, Industries, Educational, Leadership, and Partnership Opportunities. We will be accepting pre-registrations for our hybrid-University courses and accepting bid tenders for partnerships, operations and expansions in the many different industries we are targeting for the CBIS-EDP.

“Our strong partnership opportunities is the main reason our CBIS-EDP is seeing such success; for the past ten years we have built up a robust pipeline of economic growth opportunities worldwide centered around education, job creation, drug development, agriculture, high-tech, banking & finance, communications, real estate & construction, medical services, security, TV & media, mining & natural resources, political & government relations, manufacturing, teaching, sales & marketing, retail services, warehousing & distribution, and entrepreneurial business incubators for those who wish to own their own businesses and create jobs anywhere, even in your own community, in virtually any industry worldwide.

“These new initiatives have created significant reporting requirements for the Company in multiple jurisdictions worldwide, while Cannabis Science is simultaneously investing in the necessary infrastructure to successfully execute these exciting initiatives. By going private, the Company will have the opportunity to stabilize its growth and put the necessary systems in place to ensure that Cannabis Science successfully maintains its growth over the long-term, and over the short-term the Company will be able to move at the speed of light. Cannabis Science’s CEO will be empowered to move much faster to structure new partnerships and acquisitions to add value and liquidity to the Company’s shares through partnerships and acquisitions with new private and public companies operating on exchanges worldwide, to take advantage of and better align with Cannabis Science global operations.

“Over the last several years, Cannabis Science has invested heavily in its drug development, education, and economic development initiatives. As for drug development, Cannabis Science has a tremendous pipeline of potential critical ailment products and is planning for clinical trials early next year. Cannabis Science also has a number of products currently available and under development for the state and over-the-counter (OTC) markets. Similarly, Cannabis Science has made considerable progress with its education and economic development programs internationally.

"This is what it’s all about; the CBIS-EDP is real, down to earth, accessible economic development plans, industry specific enhancements, job creation, education, food and drug distribution. We have made this program available to everyone in virtually any demographic worldwide that needs economic industry stimulation or cost-effective drug development for medical issues, restructure for economic growth, education, and jobs for the people. We just made the World Series, and its game on! Looking forward to seeing you all live on iCannabinoid!” Concludes Mr. Dabney.

About Cannabis Science, Inc.

Cannabis Science is the first publicly-traded cannabinoid company on the market, and is a leader in the research and development of cannabinoid-based medicines and associated delivery technologies. Cannabis Science and its research collaborators are currently conducting pre-clinical research on cannabinoid-based medicines with plans to transition to clinical trials on a number of products this year. Targeted indications include Lung Cancer, Pancreatic Cancer, Chronic Prostatitis, Obsessive Compulsive Disorder (OCD), Oro-bucco-lingual Dyskinesias, Oxidative Stress, Psychosis, and Post Traumatic Stress Disorder (PTSD). CBIS is also currently in negotiations to license the Company’s U.S. patent number 9,763,991 for the Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, including Sleep Disorders. CBIS recently announced its drug-development pipeline (www.cannabisscience.com) and the transition into clinical trials as well as other major company initiatives.

Cannabis Science takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, neurological conditions, and other indications as identified previously. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.



Contact Information

Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-310-650-3788

www.iCannabinoid.com

Connect, Learn, and Share!

For Live Chat and Live Updates. Show more

Wowwww. Guess I really do need to be in here more often! We actually need to launch this thing properly! We have most of the pieces in place now,...Wowwww. Guess I really do need to be in here more often! We actually need to launch this thing properly! We have most of the pieces in place now, however, some priorities took over our immediate focus. This post should make up for some lost time and give some legal insight. This post should last a good minute as we proceed through our cash flow transition.

We’ll be back shortly to launch iCannabinoid properly so we can communicate with the World in an instant, with a few extra special Surprises!

Now isn’t this Great, let us waste some time responding to some more “nasty armchair experts” with more nasty directives, intentions, and of course they have no regards to any Success. We never want to justify an untruth with a non-response or even justify it with a response. However, we do get a lot of what is next questions, fair enough, however the plan is laid out.

So, I have an Idea! LET’S TURN THIS POSITIVE;

Cannabis Science, Success 101, lessons learnt.

As we all have read, we are enjoying Great Success with our Cannabis Science Economic Development Plans Worldwide! The job creation, Drug Development programs, and Industrial Hemp integration as part of our educational structures.

This even includes Entrepreneurial Programs for the people who’d Love to own their own business in any demographic, in virtually any industry. Robust we know, that is part of the plan of course, Success.

We have no time to waste, this is for our Entrepreneurial enthusiasts following our Successes, our ups and downs, and our actual path with interest and support.

So, for our “real base of support” as we are learning to call you. Here we go;

Success 101, lesson here is you are the Captain of your Ship. Let the blame jump off your ship, it is known as deadweight on a boat, not a good mix. Instead of laying the blame on these people and their bad intentions; we fix things, learn our lessons, and never let that happen again. I really don’t even know for sure how many thousands of outstanding shareholders you are strong, but out of literally thousands of outstanding shareholders we get a few rants from the “nasty armchair experts”. And I really mean a few, maybe they team up, take on a few online identities, and add some paid rah rahs to make it seem like so many. However, most of our base is supporting us through emails and phone calls for partnerships, drug development observational studies, product and patent inquiries, and many other scenarios as these. Once we move to the next stage of operations things will become much more normalized again and I can take a much-needed vacation.

Success 101, lesson learnt, Integrity, you must wholeheartedly follow your Dream, you must represent your commitment with; "Say as you Do and Do as you Say."

Success 101, lesson learnt, no matter what, no matter how long, no matter who says WHAT. Follow through with what you say, even if you MUST re-adjust your words and plans to accommodate/streamline or change situations beyond your control or even in your control that you must make decisions and take immediate action on.

Success 101, lesson learnt, life changes and so does business, own it and control it the best you can with the tools you have, in the end, it is your book, your story, your end. Not theirs. So, you say it, as many times as you want, and you do it, anyway you want, anytime you want. Say it, Do it.

Success 101, lesson learnt, BE HONORED, own it, is an Honor. I am actually very impressed and HONORED that we have such a Strong Base as we could never expect to bat 1,000. Even if we Succeeded straight out of the Box with no hiccups, we know they’d find something.

Success 101, lesson learnt, this lesson here is don’t let anyone call you down when you are the ONE doing it, chances are they are NOT and that is why they have all the time in the world to call you down just to try to trip you up. In most cases, jealously is a major factor here.

Success 101, lesson learnt, it very interesting that people like this show up at the best of worst times, and again have such Audacity and NO regards to real Success. Hmmmm. again. I hate to think most of these types don't know what real Success is and diagnose it this way, anyways. Loudly.

Success 101, lesson learnt, Things that make you go Hmmmmm, MAYBE they missed the front page of our website ?? Never mind the rest of it. Hmmmmm, WHAT is Success, who’s Success, Money Success, Assets Success, Knowledge Success, Filings Success, Hmmmm, long list it seems. Hmmmm, in what ORDER Hmmmm.

Success 101, lesson learnt, TIMING, whose timing is it ??!?!! Your timing, Money timing, Deal timing, Ego timing, Greed timing, Truth timing, hmmm ?? So many timing questions, maybe we need some armchair experts to RANT us their opinions, Nope. Success 101, lesson here, btw, everything is laid out step by step, sometimes things don’t go as you plan for any number of reasons and you must re-adjust your game plan in order to Succeed. You do not give up as they/anyone just might want you too so they can lay even MORE Blame on you and take your base, YOU fight till the end for your business/cause, that’s how you Succeed. Get one step closer and you have Succeeded, it is your Success to call, not theirs to call. If they are with you when you Succeed you will know, when you Succeed at any level, they will see it and appreciate it.

Success 101 lesson learnt, no matter what you better have fun! We have just begun moving to the next stage of our operations, “activating our cash flow projects,” its ONLY just about to start to get real Fun!

Success 101, lesson learnt, we already know that most are paid to do the nasty rant online, it is their job, so don’t get caught up in a lose/lose situation. Success 101, lesson learnt, stay your course, don’t let anyone cause any doubt in your mind about your ability or your intentions, even if it seems or they even say it and still refuse to admit it. Many paid reasons why. Success 101, lesson learnt, always be true to yourself and to God, and you will make it anywhere you want to go.


Again, MAYBE they just missed the front page of our website ??

Amen.

Again, as we laid it out, it’s a lot, and we know what to do.

Now, if you wish to invest or partner in our initiatives, or invest just to speed things up, then by all means, my email and cell number are below, otherwise we’ll see you at the Gala!


Talk soon.

Thanks Again,
Raymond
310.650.3788

raymond.dabney@cannabisscience.com Show more

Wowwww, I'll admit it has been a minute since I've logged in here, I will change that as stated in our last news release.

I've been rather busy...Wowwww, I'll admit it has been a minute since I've logged in here, I will change that as stated in our last news release.

I've been rather busy growing things and busy fixing things.

However, watching someone actually login and use "our system" to accuse ME of "fake lies" while asking about "free shares".

I think the word is Audacity, reminds me of the kid who says to Santa WHERE ARE MY PRESENTS !??!!?!!, and I'm not even Santa, anymore, Lol.

If they were to actually try to understand, the reaction would be the exact opposite, instead I guess their agenda is more important than ours!

I get it, I just don't have time for that.

Thanks for being Great Shareholders, those of you who supported us in any way, those of you who actually took the time and have looked into the successes we have had with GHC Harvard, with DFCI, with Africa, with our USA Targeted FDA Drug Development pipeline, our CBN Patent, our International University Economic Development Programs, and all the fights along the way to protect our assets and our shareholders. The History we have made along the way for the past 10 years is unparalleled, Period.

Now, we can talk "fake news" or facts.

More is coming real soon! I'm just getting warmed up in here!
Love to hear from everyone!

We are almost ready for the Party! Obviously, there are those out there that would Love to see us fail, fail, whatever, Obviously. Well, we have a little surprise for them, Obviously they can NOT see, we already MADE IT !!!

www.cannabisscience.com

Join in the Fight !!! One way or another !!!
Help us move the Ball! it is a BIG ONE now !!! and it keeps getting Bigger!

I'm about to revisit the iCannabinoid Ambassador Program, things get a little hectic out there so I had to focus for a minute, I'm back now so we can resume.

Make sure you sign up! I will be calling shortly.

www.icannabinoid.com/index.php

Talk soon.

Thanks again,
Raymond. Show more

Hey Everyone! Be sure to tune in tomorrow to watch our presentation live at the Global Health Summit at Harvard. We are on at 8:00am EST !! The...Hey Everyone! Be sure to tune in tomorrow to watch our presentation live at the Global Health Summit at Harvard. We are on at 8:00am EST !! The links to watch are below:

8am: externalmediasite.partners.org/Mediasite/Play/df26…

10:30am: externalmediasite.partners.org/Mediasite/Play/6a77…

2pm: externalmediasite.partners.org/Mediasite/Play/7959… Show more

Next month May 24-26 is the 2019 Harvard GHC Summit !!

Our team will be be attending for the 3rd year in a row and are very excited as every year it...Next month May 24-26 is the 2019 Harvard GHC Summit !!

Our team will be be attending for the 3rd year in a row and are very excited as every year it only gets bigger and better.

The Global Health Catalyst (GHC) summit is a premier yearly event at Harvard with satellite conferences in Europe and Africa dedicated to catalyzing high impact international collaborations and initiatives to eliminate global health disparities, with main focus on cancer and related diseases.

We will be presenting during the May 26th 2:00 pm Phytomedicines session: Medical Cannabis vs. the Opioid Crises and Other Plant Medicines

Check out our Action Group on iCannabinoid "Cannabis Science Global Health Summit Presentations" for pictures and our presentations from past years summits.

If you are attending please come say hi and let's connect !! Hope to see you all there !

Registration and event information:
www.globalhealthcatalystsummit.org Show more

We have a very exciting announcement today !!

Our exclusive partner in South Africa, Elpasso Farms, has just been awarded one of the first licenses to...We have a very exciting announcement today !!

Our exclusive partner in South Africa, Elpasso Farms, has just been awarded one of the first licenses to cultivate medical cannabis by the South African Health Products Regulatory Authority (SAHPRA) !

Together with Elpasso Farms we will be implementing a phytomedicines initiative in South Africa for research, development, cultivation, testing, manufacturing, and production on Elpasso’s 1,000-acre site in Cullinan, South Africa.

We will also be establishing the Pan-African Agriculture and Commerce University (PAACU). PAACU will specialize in agriculture, medicine, law, and business programs, along with a variety of certificate courses. PAACU will conduct formal research programs using a variety of cannabinoids from associated indigenous plants. PAACU will be responsible for seed incubation, growing, and cultivating various indigenous plants, that will be overseen by Cannabis Science.

Big things are coming so be sure to keep checking back on iCannabinoid for updates !!

www.otcmarkets.com/stock/CBIS/news/story Show more

Exciting news everyone !! We have expanded into the Canadian market with the formation of Cannabis Science Canada, Inc., a wholly-owned subsidiary...Exciting news everyone !! We have expanded into the Canadian market with the formation of Cannabis Science Canada, Inc., a wholly-owned subsidiary of Cannabis Science Inc.

We've begun negotiating land and licensing deals through existing license holders for the cultivation of medical hemp and cannabis in Canada, primarily to CBIS's research.

Establishing a presence in Canada is strategically important for Cannabis Science ! In addition to a potential market to sell our products, we expect to conduct some of our research and drug-development activities in Canada fairly quickly.

Check out our News Release about our expansion on our website here:
www.cannabisscience.com/2018/497-cannabis-science-… Show more

Wow !! Over 30 applicants so far for the iCannabinoid Ambassador Program in almost every sector

Agriculture
Education
Entrepreneurship & Business...Wow !! Over 30 applicants so far for the iCannabinoid Ambassador Program in almost every sector

Agriculture
Education
Entrepreneurship & Business Development
Financial
Food & Nutrition
Government Affairs
Healthcare Professionals
Legal
Media & Communications
Patients
Physicians
Public Relations & Events
Product Manufacturing
Research & Development
Sales & Marketing
Security
Technology
Other

We’re finishing off the training packages this week and then will start calling everyone to begin the program. We are very excited to begin this process and grow the community !! Show more

Another win for the industry !! Medical Marijuana Oil Bill Clears Georgia Senate voted 44-8 !

"Current state law allows individuals with 16 specific...Another win for the industry !! Medical Marijuana Oil Bill Clears Georgia Senate voted 44-8 !

"Current state law allows individuals with 16 specific conditions, including cancer, seizure disorders and Parkinson's disease, to possess the drug."

Remember to keep moving forward and celebrate the wins !

www.nytimes.com/aponline/2019/03/29/us/ap-ga-medic… Show more